Document Detail


Serum urate: a biomarker or treatment target in pediatric hypertension?
MedLine Citation:
PMID:  23736817     Owner:  NLM     Status:  In-Data-Review    
Abstract/OtherAbstract:
PURPOSE OF REVIEW: Studies have shown an association between hyperuricemia and essential hypertension in children, presenting the possibility for serum uric acid level to serve as a biomarker for diagnosis and potential treatment target.
RECENT FINDINGS: The proposed mechanism of uric acid-induced hypertension is biphasic, with a reversible early phase, implying added significance for new-onset hypertension. Current evidence shows a strong correlation between uric acid level and essential hypertension, supporting its use in diagnosis. Small studies have shown that the use of uric acid-lowering agents allopurinol and probenecid can lower blood pressure in adolescents. These medications require further study in large populations and careful consideration of their side-effect profiles prior to clinical use as antihypertensive agents. Recent studies have also linked dietary fructose intake to hyperuricemia and hypertension, but the clinical effect of fructose reduction on blood pressure has not been confirmed.
SUMMARY: Current evidence supports use of serum uric acid level as a biomarker for diagnosis of essential hypertension in children. More research is needed to evaluate the utility of pharmacologic and nonpharmacologic means of serum uric acid reduction prior to clinical use as a therapy for hypertension.
Authors:
Megan Yanik; Daniel I Feig
Related Documents :
543877 - Distribution of pyrrolidinomethyl-tetracycline (rolitetracycline) and tetracycline in b...
24437787 - The effect of nearby timpani strokes on horn playing.
17015007 - Leachate injection using vertical wells in bioreactor landfills.
11035457 - Hypertension awareness, detection and treatment in a university community: results of a...
16602677 - A brief history of aneurysm clips.
2843197 - Pharmacokinetics of single and consecutive doses of cilazapril and its depressor effect...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Current opinion in cardiology     Volume:  28     ISSN:  1531-7080     ISO Abbreviation:  Curr. Opin. Cardiol.     Publication Date:  2013 Jul 
Date Detail:
Created Date:  2013-06-05     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8608087     Medline TA:  Curr Opin Cardiol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  433-8     Citation Subset:  IM    
Affiliation:
aDepartment of Pediatrics bDepartment of Pediatrics, Division of Nephrology, School of Medicine, University of Alabama, Birmingham, Alabama, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Is chlorthalidone better than hydrochlorothiazide in reducing cardiovascular events in hypertensives...
Next Document:  What should be the blood pressure target for patients with chronic kidney disease?